Monitor the patient regularly with documented local safety monitoring policies and procedures, including audit, for adults, children, and young people receiving treatment that needs monitoring NICE NG130.
For children and young people, monitor growth and pubertal development against expected values on centile charts or z scores at intervals such as every 3 to 6 months during active disease or puberty, every 6 months during pubertal growth if inactive, and annually if none of these criteria apply NICE NG130.
Monitor pubertal development using Tanner staging through screening questions or formal examination, and consider referral to a paediatrician if pubertal progress is slow or development is delayed NICE NG130.
Ensure that information about monitoring of growth, pubertal development, and disease activity is shared across services to maintain continuity of care NICE NG130.